Adverse event due to a likely interaction between sodium aescinate and ginkgo biloba extract: a case report

Journal of Clinical Pharmacy and Therapeutics

Volumn 42, Issue 2, 2017, Pages 237-238

  Ji, H ^a   Zhang, G ^b   Yue, F ^a   Zhou, X ^a  

^a The Sixth Affiliated Hospital of Nantong University   (China)

^b Yancheng Institute of Health Science   (China)

Author keywords

adverse effect; drug drug interactions; metabolism

Indexed keywords

CREATININE; ESCIN; GINKGO BILOBA EXTRACT; NITROGEN; PROCALCITONIN; UREA; CYTOCHROME P450 2C9; CYTOCHROME P450 3A; PLANT EXTRACT; PROTEIN BINDING; SAPONIN; SODIUM AESCINATE; TRITERPENE;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DRUG EFFECT; DRUG POTENTIATION; DRUG SAFETY; HUMAN; LIVER METABOLISM; MALE; MIDDLE AGED; PHALANX FRACTURE; PROTEIN BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; WOUND HEALING; CHEMICALLY INDUCED; HERB DRUG INTERACTION; PHYSIOLOGY;

ACUTE KIDNEY INJURY; CYTOCHROME P-450 CYP2C9; CYTOCHROME P-450 CYP3A; HERB-DRUG INTERACTIONS; HUMANS; MALE; MIDDLE AGED; PLANT EXTRACTS; PROTEIN BINDING; SAPONINS; TRITERPENES;

EID: 85014307194     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/jcpt.12500     Document Type: Article

References (11)

1. Tschesche R, Wulff G. On the antimicrobial action of saponins. Zeitschrift fur Naturforschung B, 1965;20:543–546.
2. Pittler MH, Ernst E. Horse-chestnut seed extract for chronic venous insufficiency. Arch Dermatol, 1998;134:1356–1360.
3. Guillaume M, Padioleau F. Veinotonic effect, vascular protection, antiinflammatory and free radical scavenging properties of horse chestnut extract. Arzneimittelforschung, 1994;44:25–35.
4. Annoni F, Mauri A, Marincola F, Resele LF. Venotonic activity of escin on the human saphenous vein. Arzneimittelforschung, 1979;29:672–677.
5. Sirtori CR. Aescin: pharmacology, pharmacokinetics and therapeutic profile. Pharmacol Res, 2001;44:183–193.
6. Pill MW, ONeill CV, Chapman MM, Singh AK. Suspected acute interstitial nephritis induced by piperacillin-tazobactam. Pharmacotherapy, 1997;17:166–169.
7. Matsuda H, Li Y, Yoshikawa M. Possible involvement of 5-HT and 5-HT2 receptors in acceleration of gastrointestinal transit by escin Ib in mice. Life Sci, 2000;66:2233–2238.
8. Gaudineau C, Beckerman R, Welbourn S, Auclair K. Inhibition of human P450 enzymes by multiple constituents of the Ginkgo biloba extract. Biochem Biophys Res Commun, 2004;318:1072–1078.
9. Chandra RH, Veeresham C. Herb–drug interaction of noni juice and Ginkgo biloba with phenytoin. Pharmacogn J, 2011;2:33–41.
10. Huang Y, Zheng SL, Zhu HY, Xu ZS, Xu RA. Effects of aescin on cytochrome P450 enzymes in rats. J Ethnopharmacol, 2014;151:583–590.
11. Wu XJ, Cui XY, Gao F, Guan X, He Q, Gu JK. Study on plasma protein binding rate of escin A in rat’plasma. Chin J Clin Pharmacol, 2015;31:358–361.